HCAL
ITOS icon

HURRICANE CAPITAL ADVISORS LLC’s iTeos Therapeutics ITOS Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,265
Closed -$48.1K – 636
2024
Q4 		$48.1K Buy
+6,265
New +$53.8K 0.01% 397
2024
Q2 		– Sell
-1,985
Closed -$27.1K – 525
2024
Q1 		$27.1K Hold
1,985
– – 0.01% 468
2023
Q4 		$21.7K Buy
+1,985
New +$19.7K 0.01% 427

Other funds holding ITOS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
MPM Asset Management
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Tang Capital Management
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
MPM BioImpact
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's ITOS Position: Q1 2025 in Review

HURRICANE CAPITAL ADVISORS LLC sold out of iTeos Therapeutics (ITOS) in Q1 2025, closing a stake of 6,265 shares — an estimated $48.1K sold.

HURRICANE CAPITAL ADVISORS LLC first reported a position in ITOS in Q4 2023 and held it in 3 quarters. The position peaked at $48.1K in Q4 2024. 132 funds tracked by Wall St. Rank hold ITOS as of Q1 2025.

  • HURRICANE CAPITAL ADVISORS LLC reported no remaining iTeos Therapeutics position as of Q1 2025 after selling out during the quarter.
  • HURRICANE CAPITAL ADVISORS LLC sold 6,265 iTeos Therapeutics shares in Q1 2025, an estimated $48.1K.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in iTeos Therapeutics in Q4 2023 and held it in 3 quarters.
  • HURRICANE CAPITAL ADVISORS LLC's iTeos Therapeutics position peaked at $48.1K in Q4 2024.
  • 132 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q1 2025.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q1 2025, filed 3 Nov 2026.